edoc

Items where Author is "Yang, M."

Up a level
Export as [feed] Atom [feed] RSS 1.0 [feed] RSS 2.0
Group by: Date | Item Type | Refereed
Jump to: Article
Number of items: 5.

Article

MacManus, D. G. and Miller, D. H. and Kappos, L. and Gold, R. and Havrdova, E. and Limmroth, V. and Polman, C. H. and Schmierer, K. and Yousry, T. A. and Eraksoy, M. and Meluzinova, E. and Dufek, M. and Yang, M. and O'Neill, G. N. and Dawson, K.. (2011) BG-12 reduces evolution of new enhancing lesions to T1-hypointense lesions in patients with multiple sclerosis. Journal of neurology, Vol. 258, H. 3. pp. 449-456.

Ge, J. F. and Arai, C. and Yang, M. and Bakar, M. A. and Lu, J. and Ismail, N. S. M. and Wittlin, S. and Kaiser, M. and Brun, R. and Charman, S. A. and Nguyen, T. and Morizzi, J. and Itoh, I. and Ihara, M.. (2010) Discovery of novel benzo[a]phenoxazine SSJ-183 as a drug candidate for malaria. ACS medicinal chemistry letters, Vol. 1, H. 7. pp. 360-364.

Yang, M. and Arai, C. and Bakar, M. A. and Lu, J. and Ge, J. F. and Pudhom, K. and Takasu, K. and Kasai, K. and Kaiser, M. and Brun, R. and Yardley, V. and Itoh, I. and Ihara, M.. (2010) Fluorinated rhodacyanine (SJL-01) possessing high efficacy for visceral leishmaniasis (VL). Journal of medicinal chemistry, 53 (1). pp. 368-373.

Pudhom, K. and Ge, M. F. and Arai, C. and Yang, M. and Kaiser, M. and Wittlin, S. and Brun, R. and Itoh, I. and Ihara, M.. (2009) Synthesis and biological properties of a rhodacyanine derivative, Ssj-127, having high efficacy against malaria protozoa. Heterocycles : an international journal for reviews and communications in heterocyclic chemistry, Vol. 77, H. 1. pp. 207-210.

Kappos, L. and Gold, R. and Miller, D. H. and Macmanus, D. G. and Havrdova, E. and Limmroth, V. and Polman, C. H. and Schmierer, K. and Yousry, T. A. and Yang, M. and Eraksoy, M. and Meluzinova, E. and Rektor, I. and Dawson, K. T. and Sandrock, A. W. and O'Neill, G. N.. (2008) Efficacy and safety of oral fumarate in patients with relapsing-remitting multiple sclerosis: a multicentre, randomised, double-blind, placebo-controlled phase IIb study. Lancet, Vol. 372. pp. 1463-1472.

This list was generated on Sun Oct 17 18:00:49 2021 CEST.